Technology has granted us the ultimate modern freedom: the ability to conquer darkness.
Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to ...
Hernando Salcedo was diagnosed with Stage III pancreatic cancer after mild symptoms. Chemotherapy made him feel worse than ...
Researchers from the University of Minnesota Medical School have identified why pancreatic cancer is difficult for the immune ...
Neurological and pancreatic complications are common in patients with congenital hyperinsulinism, according to a systematic ...
Topline phase 3 SHASTA-3 and SHASTA-4 trial data show plozasiran reduced triglycerides by up to 81% and acute pancreatitis events by 78% in severe HTG.
Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to ...
Researchers tested experimental PCAI compounds against pancreatic cancer cells and found they had powerful anticancer effects. One leading compound blocked more than 90% of cancer cell migration, ...
Morning Overview on MSN
A new blood test caught 90% of early pancreatic cancers usually found too late
A pilot blood test built on whole-blood mRNA signatures detected nine of ten early-stage pancreatic ductal adenocarcinoma ...
Pancreatic ductal adenocarcinoma is a common malignancy of the gastrointestinal tract. The number of new cases diagnosed and the number of deaths each year are almost identical, demonstrating the ...
Those with pathologically confirmed pancreatic precursor lesions and their first-degree relatives have significantly higher risk for pancreatic cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results